WVU Clinical Trials Research Unit among top ten nationally for clinical trials accrual

WVU Clinical Trials Research Unit among top ten nationally for clinical trials accrual

Congratulations to the WVU Clinical trials Research Unit (CTRU) and Dr. Adham Salkeni, WVU’s principal investigator for the NRG Oncology group, the largest clinical trials collaborative network in the United States.  During the recent biannual meeting of the NRG, our CTRU was recognized as among the top ten main member sites to enroll the most patients on cancer clinical trials between January and June 2017.  “This places WVU on the national map for clinical trials accrual,” Salkeni said.  “This shows that we offer state-of-the-art research studies that examine the role of targeted therapies for the treatment of a wide variety of cancers that affect our patient population.”

-SS-
  • Gibson selected as an Executive Leadership in Academic Medicine Fellow

    Gibson selected as an Executive Leadership in Academic Medicine Fellow

    Lauren F. Gibson, Ph.D., senior associate vice president for research and graduate education at WVU Health Sciences, has been selected as a fellow in the Hedwig van Ameringen Executive Leadership in Academic Medicine Program for Women at Drexel University College of Medicine.

    Read More

  • Patrick Ma lab presents research at ASCO meeting, Xiaoliang Wu wins Merit Award

    Patrick Ma lab presents research at ASCO meeting, Xiaoliang Wu wins Merit Award

    Patrick Ma, M.D., co-leader of the WVU Cancer Institute Sara Crile Allen & James Frederick Allen Comprehensive Lung Cancer Program and director of the Clinical Lung Cancer Program, and Xiaoliang Wu, M.D., Ph.D., postdoctoral research fellow in Dr. Ma’s lab, were featured presenters at the 2018 American Society of Clinical Oncology (ASCO) Annual Scientific Meeting this June.

    Read More

  • NIH Funding Opportunities Available for High-Risk Research

    NIH Funding Opportunities Available for High-Risk Research

    The National Institutes of Health (NIH) Common Fund announces fiscal year 2019 funding opportunities for the NIH Director’s Pioneer Award, New Innovator Award, Transformative Research Award, and Early Independence Award in the High-Risk, High-Reward Research program.

    Read More